Clinical trial
Clinical Investigation of Cardioprotective Effect of Early Administration of Sodium-glucose Cotransport-2 Inhibitors in Patients With Acute Myocardial Infarction
NCT06009874 is registered in ClinicalTrials.gov with Mohammad Hussien Tantawy Soliman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Investigation of Cardioprotective Effect of Early Administration of Sodium-glucose Cotransport-2 Inhibitors in Patients With Acute Myocardial Infarction
- Lead sponsor
- Mohammad Hussien Tantawy Soliman
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 20, 2023
- Completion date
- August 31, 2028
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.